Search

Your search keyword '"Ray KK"' showing total 463 results

Search Constraints

Start Over You searched for: Author "Ray KK" Remove constraint Author: "Ray KK" Language english Remove constraint Language: english
463 results on '"Ray KK"'

Search Results

1. International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia

3. Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study

4. Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

5. Effect of inclisiran, the siRNA against PCSK9, on platelets, immune cells and immunological biomarkers - a pre-specified analysis from ORION-1

8. LDL-cholesterol lowering strategies and population health - time to move to a cumulative exposure model

9. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

10. Reducing the clinical and public health Burden of Familial hypercholesterolemia

11. Targeting PCSK9: Implications for basic science and upcoming challenges

12. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

13. Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

14. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

15. Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial

16. Major lipids, apolipoproteins, and risk of vascular disease

17. LDL-Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men with Primary Elevations of LDL-Cholesterol Levels of 190 mg/dL or Above: Analyses from the WOSCOPS 5-year Randomised Trial and 20-year Observational Follow-Up

18. Long-term mortality following acute myocardial infarction among those with and without diabetes: A systematic review and meta-analysis of studies in the post reperfusion era

19. Determining When to Add Nonstatin Therapy: A Quantitative Approach

20. A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important?

22. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

23. Emerging Risk Factors Collaboration. Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies

24. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: Evidence from genetic analysis and randomised trials

25. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality

26. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

27. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

28. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

45. Cardiac rehabilitation versus standard care after aortic aneurysm repair (Aneurysm CaRe): study protocol for a randomised controlled trial

Catalog

Books, media, physical & digital resources